JOTROL
Asset
Bioavailability-enhanced resveratrol formulation intended to reduce oxidative stress and neuroinflammation.
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- Oxidative stress and ROS signalling
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Parkinson's disease
Phase 2, longevity.technology, 9 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Evidence for its targets2
- Competitors12
- Aging relevance1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.